2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Cited by (1,003)

Items 401–500 of 1,003

  1. Association of peripheral CD8 + T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Yuya Fujita, Shingo Nakayamada, Satoshi Kubo, Yusuke Miyazaki, Koshiro Sonomoto, Hiroaki Tanaka, Yoshiya Tanaka · 2025 · RMD Open
  2. Tracking clonal dynamics of CD8 T cells and immune dysregulation in progression of systemic lupus erythematosus with nephritis
    Seung-Jun Paek, Hye‐Soon Lee, Ye Ji Lee, So‐Young Bang, Dong‐Ju Kim, Bo-Kyeong Kang, Dae Jin Park, Young Bin Joo, Mimi Kim, Hyunsung Kim et al. · 2025 · Experimental & Molecular Medicine
  3. Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study
    Kasturi Hazarika, Rasmi Ranjan Sahoo, Namita Mohindra, Archana Wakhlu, Manesh Manoj, Prashant Bafna, Rajiv Garg, Durga Prasanna Misra, Vikas Agarwal, Anupam Wakhlu · 2021 · Rheumatology International
  4. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study
    Laure Ricard, Charlotte Laurent, Matthias Papo, Sophie Deriaz, Jennifer Catano, Sonia Alamowitch, Gilles Kayem, François Chasset, Claire DE MOREUIL, J.J. Boffa et al. · 2021 · Joint Bone Spine
  5. Acute Pericarditis Leading to a Diagnosis of SLE: A Case Series of 3 Patients
    Vishal K. Narang, Jonathan Bowen, Omar Masarweh, Shane Burnette, Michael C. Valdez, Leila Moosavi, Fowrooz Joolhar, Theingi Tiffany Win · 2022 · Journal of Investigative Medicine High Impact Case Reports
  6. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
    Samar A. Soliman, Samantha K. Stanley, Kamala Vanarsa, Faten M. Ismail, Chi Chiu Mok, Chandra Mohan · 2022 · Frontiers in Immunology
  7. Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus
    Katarzyna M. Fischer, Hanna Przepiera‐Będzak, Iwona Brzosko, Marcin Sawicki, Anna Walecka, Marek Brzosko · 2022 · Biomolecules
  8. Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance
    Brian R. Stotter, Ellen M. Cody, Hongjie Gu, Ankana Daga, Larry A. Greenbaum, Minh Dien Duong, Alexandra Mazo, Béatrice Goilav, Alexis D. Boneparth, Mahmoud Kallash et al. · 2022 · Pediatric Nephrology
  9. Epidemiology of Cutaneous Lupus Erythematosus Among Adults Over Four Decades (1976-2018): A Lupus Midwest Network (LUMEN) Study
    Mehmet Hocaoǧlu, Mark D.P. Davis, Shirley‐Ann Osei‐Onomah, Maria O Valenzuela-Almada, Jesse Y. Dabit, Stephanie Q. Duong, Jeffrey X. Yang, Charles G. Helmick, Cynthia S. Crowson, Alí Duarte‐García · 2022 · Mayo Clinic Proceedings
  10. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases
    Haitao Yang, Xiaoping Hong, Jie-Wen Guo, Xiao-Ling Zhong, Rui Liao, Cuilian Liu, Lixiong Liu, Kai Li, Yu-Lan Chen, Dongzhou Liu · 2023 · Journal of Immunology Research
  11. Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry
    Michael Heming, Louisa Müller‐Miny, Leoni Rolfes, Andreas Schulte‐Mecklenbeck, Tobias Johannes Brix, Julian Varghese, Marc Pawlitzki, Hermann Josef Pavenstädt, Martin Alexander Kriegel, Catharina C. Groß et al. · 2023 · Journal of Neuroinflammation
  12. New concepts on abnormal UV reactions in systemic lupus erythematosus and a screening tool for assessment of photosensitivity
    Danielle A. Corbin, Lea Christian, Christine M. Rapp, Langni Liu, Craig A. Rohan, Jeffrey Bryant Travers · 2023 · Skin Research and Technology
  13. Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
    Evgeny Lvovich Nasonov, Z. N. Sukmarova, Т. В. Попкова, Boris Sergeyevich Belov · 2023 · Rheumatology Science and Practice
  14. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus
    Sung Kyung Cho, Thomas Vazquez, Victoria P. Werth · 2023 · Expert Opinion on Investigational Drugs
  15. Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner
    Carlos Rafael‐Vidal, Sara Martínez-Ramos, Beatriz Malvar‐Fernández, Irene Altabás‐González, Coral Mouriño, Douglas James Veale, Achilleas Floudas, Ursula Fearon, José María Pego‐Reigosa, Samuel García · 2023 · Frontiers in Immunology
  16. Declining Incidence of Systemic Lupus Erythematosus in Norway 1999–2017: Data From a Population Cohort Identified by International Classification of Diseases, 10th Revision Code and Verified by Classification
    Hilde Haukeland, Sigrid Reppe Moe, Cathrine Brunborg, Antonela Botea, Nenad Damjanic, Gro Årthun Wivestad, Heidi Kverneggen Øvreås, Thea Bøe, Anniken Orre, Torhild Garen et al. · 2023 · Arthritis & Rheumatology
  17. Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
    Patricia Katz, Claire E.H. Barber, Alí Duarte‐García, Shivani Garg, Wambui Machua, Wendy Rodgers, Yesenia Santiago‐Casas, Lisa Gale Suter, Christie Michels Bartels, Jinoos Yazdany · 2024 · Arthritis Care & Research
  18. A potential biomarker of disease activity in systemic lupus erythematosus, systemic immune-inflammation index
    Muhammet Recai Akdoğan · 2024 · Northern Clinics of Istanbul
  19. Central Nervous System Involvement in Systemic Autoimmune Rheumatic Diseases—Diagnosis and Treatment
    Aline Juncker, Simone Appenzeller, Jean Marcos de Souza · 2024 · Pharmaceuticals
  20. French protocol for the diagnosis and management of systemic lupus erythematosus
    Zahir Amoura, Brigitte Bader‐Meunier, Marie Antignac, Nathalie Bardin, Cristina C. Belizna, Alexandre Bélot, Bernard Bonnotte, Jean‐David Bouaziz, François Chasset, Laurent Chiche et al. · 2024 · La Revue de Médecine Interne
  21. Auto-immuno-deficiency syndromes
    Gunnar Houen · 2024 · Autoimmunity Reviews
  22. High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease
    Bernardo D’Onofrio, Giulia Virelli, Elisa Pedrollo, Marta Caprioli, Marta Riva, Daniela Renna, Antonio Tonutti, Nicoletta Luciano, Angela Ceribelli, Elisa Gremese et al. · 2024 · Rheumatology Advances in Practice
  23. Simultaneous Multi-miRNA Detection in Urinary Small Extracellular Vesicles Using Target-Triggered Locked Hairpin DNA-Functionalized Au Nanoprobes for Systemic Lupus Erythematosus Diagnosis
    Xiaofei Chen, Qingyong Xiang, Shaohan Yan, Yingyu Wang, Ning Su, Xue Yang, Mingxia Gao, Xiangmin Zhang · 2024 · Analytical Chemistry
  24. Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study
    Yinv Gong, Shuhua Liu, Haimei Liu, Yu Shi, Yifan Li, Wanzhen Guan, Qiaoqian Zeng, Qianying Lv, Xiaomei Zhang, Qijiao Wei et al. · 2024 · Lupus Science & Medicine
  25. Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort
    Manuel Francisco Ugarte-Gil, Guillermo Pons‐Estel, Guillermina Harvey, Luis M. Vilá, Russell Lee Griffin, Graciela S. Alarcón · 2020 · Arthritis Care & Research
  26. The clinical and the laboratory autoimmunologist: Where do we stand?
    Renato Tozzoli, Nicola Bizzaro · 2020 · Autoimmunity Highlights
  27. Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia
    Francesco Saettini, Alessandro Cattoni, Martina Baiardo Redaelli, Daniela Silvestri, Giulia Maria Ferrari, Andrea Biondi, Momcilo Jankovic, Marco Spinelli · 2020 · Acta Paediatrica
  28. Clinical and laboratory profile of systemic lupus erythematosus patients at a rural tertiary centre in South-South Nigeria: experience from a new rheumatology clinic
    Airenakho Emorinken, Mercy Ofunami Dic‐Ijiewere, Cyril Oshomah Erameh, Asuwemhe Johnson Ugheoke, Oluwaseun Remi Agbadaola, Folasade Ojuolape Agbebaku · 2021 · Reumatologia/Rheumatology
  29. Interkit Reproducibility of the Indirect Immunofluorescence Assay on HEp-2 Cells Depends on the Immunofluorescence Reactivity Intensity and Pattern
    Mônica Jesus Silva, Alessandra Dellavance, Danielle Cristiane Baldo, Sílvia Helena Rodrigues, Marcelle Grecco, Mônica Simon Prado, Renan de Almeida Agustinelli, Luís Eduardo Coelho Andrade · 2022 · Frontiers in Immunology
  30. Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response
    Jan‐Mou Lee, Ming‐Huang Chen, Kai-Yuan Chou, Yee Chao, Ming‐Han Chen, Chang‐Youh Tsai · 2022 · Lupus Science & Medicine
  31. Evaluation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in children and adults
    Sang Cheng, Huihua Ding, Haiyan Xue, Lanfang Cao · 2022 · Clinical Rheumatology
  32. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans
    Isaac T. W. Harley, Kristen Allison, Robert Hal Scofield · 2022 · Frontiers in Immunology
  33. Diagnostic accuracy of the European League against rheumatism/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis
    Wentian Lu, Fengmei Tian, Jinlu Ma, Ying Zhong, Zhichun Liu, Leixi Xue · 2022 · Frontiers in Immunology
  34. Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
    Takayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, So Takata, Yuko Abe, Takuro Nii, Tomoki Kuge, Shinichi Iwakoshi, Takayuki Shiroyama, Kotaro Miyake et al. · 2023 · RMD Open
  35. Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review
    Rosanna Lacetera, Marta Calatroni, Letizia Roggero, Antonella Radice, Maria Rosa Pozzi, Francesco Reggiani, Savino Sciascia, Barbara Trezzi, Dario Roccatello, Enrico Eugenio Minetti et al. · 2023 · Journal of Nephrology
  36. Diagnosis and natural history of preclinical and early inflammatory bowel disease
    Iago Rodríguez–Lago · 2020 · Annals of Gastroenterology
  37. New lupus criteria: a critical view
    Martin Aringer, Sindhu R. Johnson · 2020 · Current Opinion in Rheumatology
  38. Safety and Efficacy of PD-1/PD-L1 Inhibitors in Cancer Patients With Preexisting Autoantibodies
    Hui Jun Tang, Ruixuan Geng, Xiuxiu Xu, Yingyi Wang, Jiaxin Zhou, Shulan Zhang, Lin Zhao, Mei Guan, Chunmei Bai · 2022 · Frontiers in Immunology
  39. Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
    Ilaria Mormile, Francesca Della Casa, Angelica Petraroli, Alessandro Furno, Francescopaolo Granata, Giuseppe Portella, Francesca Wanda Rossi, Amato de Paulis · 2022 · Vaccines
  40. Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus
    Hugo J. van Dooren, Yemil Atisha‐Fregoso, Annemarie L Dorjée, Tom W. J. Huizinga, Meggan C. Mackay, Cynthia B. Aranow, René E. M. Toes, Betty Diamond, Jolien Suurmond · 2025 · Journal of Autoimmunity
  41. Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy
    Kathryn D. Hok, Haydn E. Rich, Anthony Shadid, Lavanya Gunamalai, Tingting Mills, Rajarajan A. Thandavarayan, Nirmal K. Banda, Marie–Françoise Doursout, Marcos I. Restrepo, Pooja Shivshankar · 2025 · International Journal of Molecular Sciences
  42. CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT
    Nathalie Morel, Clémence Bonnet, Hanane Mehawej, Véronique Le Guern, Laurent Pérard, Mathilde Roumier, Antoine Pierre Brézin, Bertrand Godeau, Julien Haroche, Y. Benhamou et al. · 2021 · Retina
  43. Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome
    Young Gi Min, Woohee Ju, Jae-Woo Seo, Ye-Eun Ha, Jae‐Jun Ban, Young Nam Kwon, Han‐Yeong Jeong, Je-Young Shin, Sung‐Min Kim, Yoon‐Ho Hong et al. · 2022 · Journal of the Neurological Sciences
  44. Dental caries and risk of newly-onset systemic lupus erythematosus: a nationwide population-based cohort study
    Wuu‐Tsun Perng, Kevin Sheng‐Kai, Hsin-Yu Hung, Yi-Chieh Tsai, Jing‐Yang Huang, Pei‐Lun Liao, Yao‐Min Hung, James Cheng‐Chung Wei · 2022 · Current Medical Research and Opinion
  45. Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production
    Iris Karina Madera-Salcedo, Ada L. Ramírez‐Sánchez, Noé Rodríguez‐Rodríguez, Roberto García‐Quintero, Rosa Maria Rubio, Gabriela Morales‐Montes de, Emmanuel Dávalos, Rogelio Cuervo, Janette Furuzawa‐Carballeda, Jorge Carlos Alcocer-Varela et al. · 2022 · Arthritis & Rheumatology
  46. Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
    Hanna Nurmi, Pia Elfving, Hannu-Pekka Kettunen, Sanna-Katja Suoranta, Henrik M. I. Järvinen, Vili A. E. Kuittinen, Minna Purokivi, Riitta L. Kaarteenaho, Heikki Olavi Koskela · 2023 · Journal of Thoracic Disease
  47. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus
    Shaimaa M Kamel, Mervat E Abdel Azeem, Rabab Mohamed, Mahmoud Mohamed Kamel, Enas A Abdel Aleem · 2023 · International Journal of Immunopathology and Pharmacology
  48. Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study
    Hongjia Du, Wei Su, Jiang Su, Jiarui Hu, Dongze Wu, Wubin Long, Jing Hai Zhu · 2023 · Lara D. Veeken
  49. Causes of Polyserositis: A Systematic Review
    Laura Elena Stoichitoiu, Georgeta Daniela Ionescu, Ingrid Neatu, Cristian Băicuş · 2023 · Journal of Personalized Medicine
  50. BAFFR expression in circulating T follicular helper (CD4 + CXCR5 + PD-1 + ) and T peripheral helper (CD4 + CXCR5 − PD-1 + ) cells in systemic lupus erythematosus
    Nefertari Sagrero‐Fabela, Pablo Cesar Ortiz‐Lazareno, Diana Celeste Salazar‐Camarena, Álvaro Cruz, Sergio Cerpa‐Cruz, José Francisco Muñóz-Valle, Miguel Marín‐Rosales, Jhonatan Antonio Alvarez‐Gómez, Claudia Azucena Palafox‐Sánchez · 2023 · Lupus
  51. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
    Nayra Merino de Paz, María García-González, Fuensanta Gómez-Bernal, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Raquel López‐Mejías, Pedro Abreu-González, Candelaria Martín‐González, Miguel Ángel González-Gay, Iván Ferraz‐Amaro · 2023 · Antioxidants
  52. Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients
    Shudan Wang, Anna R. Broder, Daming Shao, Vartika Kesarwani, Brianna Boderman, Jennifer T. Aguilan, Simone Sidoli, Masako Suzuki, John M. Greally, Yvonne M. Saenger et al. · 2023 · Seminars in Arthritis and Rheumatism
  53. Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus
    Ting‐Wei Lin, Yu‐Tsan Lin, Ya‐Chiao Hu, Hsin‐Hui Yu, Bor‐Luen Chiang · 2024 · Lupus Science & Medicine
  54. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
    Irene Cecchi, Massimo Radin, Alice Barinotti, Silvia Grazietta Foddai, Elisa Menegatti, Dario Roccatello, Ana Suárez, Savino Sciascia, Javier Rodríguez‐Carrio · 2024 · Frontiers in Immunology
  55. bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease
    Peter Kvacskay, Ute Hegenbart, Hanns‐Martin Lorenz, Stefan Olaf Schönland, Norbert Blank · 2024 · Annals of the Rheumatic Diseases
  56. Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort
    Yufang Ding, Yangzhong Zhou, Feng Zhan, Jian Xu, Xinwang Duan, Hui Luo, Cheng Zhao, Min Yang, Rui Wu, Lijun Wu et al. · 2024 · Med
  57. Eighty‐six cases of clinical characteristics and outcomes of systemic lupus erythematosus‐associated macrophage activation syndrome: A meta‐analysis study
    Jingya Wang, Wei Rong, Haotian Yan · 2024 · Immunity Inflammation and Disease
  58. Deep Reinforcement Learning for personalized diagnostic decision pathways using Electronic Health Records: A comparative study on anemia and Systemic Lupus Erythematosus
    Lillian Muyama, Antoine Neuraz, Adrien Coulet · 2024 · Artificial Intelligence in Medicine
  59. Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology
    Hunter DeVaughn, Haydn E. Rich, Anthony Shadid, Priyanka K. Vaidya, Marie–Françoise Doursout, Pooja Shivshankar · 2024 · International Journal of Molecular Sciences
  60. A20 haploinsufficiency diagnosis beyond systemic lupus erythematosus: A systematic review of the literature
    Rémi Philip, Inès Elhani, Sophie Gallou, Hubert de BOYSSON, Nicolas Martin Silva, Sophie Georgin‐Lavialle, Samuel Deshayes, Achille Aouba · 2024 · Autoimmunity Reviews
  61. Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort
    Manuel Francisco Ugarte-Gil, Guillermo Pons‐Estel, Russell Lee Griffin, Luis M. Vilá, John D. Reveille, Graciela S. Alarcón · 2020 · Arthritis Care & Research
  62. Cell-bound complement activation products associate with lupus severity in SLE
    Cristina Arriens, Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E. Collins, Daniel J. Wallace, Elena M. Massarotti, John Conklin, KENNETH C. KALUNIAN, Chaim Putterman et al. · 2020 · Lupus Science & Medicine
  63. Turn the light on photosensitivity
    Bernadett Kurz, Irina Ivanova, Wolfgang Bäumler, Mark Berneburg · 2021 · Journal of Photochemistry and Photobiology
  64. Understand SLE heterogeneity in the era of omics, big data, and artificial intelligence
    Prianka Puri, Simon Jiang, Yang Yang, Fabienne Mackay, Di Yu · 2021 · Rheumatology & autoimmunity
  65. Cardiovascular Manifestations, Imaging, and Outcomes in Systemic Lupus Erythematosus: An Eight-Year Single Center Experience in the United States
    Tom Kai Ming Wang, Nicholas Chan, Mohamed Khayata, Patrick T. Flanagan, Richard A. Grimm, Brian P. Griffin, M. Elaine Husni, Emily Littlejohn, Bo Xu · 2022 · Angiology
  66. Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus
    Sulaiman Mohammed Al-Mayouf, Lujayn Akbar, Reem Abdwani, Giulia Ginesi, Stefano Volpi, Marco Gattorno, Reima Bakry, Samia AlHashim, Alhanouf AlSaleem · 2022 · Clinical Rheumatology
  67. Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre
    Giuseppe Barilaro, Emmanuel Coloma, Chafik Alejandro Chacur, Carlo Della Rocca, Albert Pérez-Isidro, Estíbaliz Ruiz‐Ortiz, Odette Viñas, Dolors Tàssies Penella, Joan Carles Reverter, Alícia Molina Andújar et al. · 2022 · Autoimmunity Reviews
  68. Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
    Jingquan He, Chiyu Ma, Donge Tang, Shaoyun Zhong, Xiaofang Yuan, Fengping Zheng, Zhipeng Zeng, Yumei Chen, Dongzhou Jeffrey Liu, Xiaoping Hong et al. · 2022 · Frontiers in Immunology
  69. Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus
    Ágnes Diószegi, Hajnalka Lőrincz, Eszter Kaáli, Pál Soltész, Bianka Perge, Éva Varga, Mariann Harangi, Tünde Tarr · 2023 · Biomolecules
  70. Systemic Lupus Erythematosus in Children
    Kunal Chandwar, Amita Aggarwal · 2023 · The Indian Journal of Pediatrics
  71. A new therapeutic target for systemic lupus erythematosus: the current landscape for drug development of a toll-like receptor 7/8 antagonist through academia-industry-government collaboration
    Yoshiya Tanaka, Fumitoshi Tago, Naoto Yamakawa, Mari Aoki, Takuya Yagi, Shizuo Akira · 2023 · Immunological Medicine
  72. Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
    Lorenza Maria Argolini, Giulia Frontini, Elena Elefante, Francesca Saccon, Valentina Binda, Chiara Tani, Isabella Scotti, Linda Carli, Mariele Gatto, Ciro Esposito et al. · 2020 · Journal of Nephrology
  73. Outcome and prognostic factors of interstitial lung disease patients with acute respiratory failure in the intensive care unit
    Wei-Ling Lain, Shi-Chuan Chang, Wei‐Chih Chen · 2020 · Therapeutic Advances in Respiratory Disease
  74. Neuropsychiatric disorders: An immunological perspective
    Ernest Aw, Yingying Zhang, Esra Yalçın, U. Herrmann, Michael C. Carroll · 2021 · Advances in immunology
  75. B Cell–Specific Deletion of CR6‐Interacting Factor 1 Drives Lupus‐like Autoimmunity by Activation of Interleukin‐17, Interleukin‐6, and Pathogenic Follicular Helper T Cells in a Mouse Model
    Jin‐Sil Park, SeungCheon Yang, Sun‐Hee Hwang, JeongWon Choi, Seung‐Ki Kwok, Young‐Yun Kong, Jeehee Youn, Mi‐La Cho, Sung‐Hwan Park · 2022 · Arthritis & Rheumatology
  76. Identification of novel autoantibodies in Sjögren’s disease
    Fiona Engelke, Petra Ilse Budde, Salvatore De Vita, Thomas Dörner, Diana Ernst, Jan Christoph Gras, Harald Heidecke, Annika Loredana Kilian, Katja Kniesch, Ann-Sophie Lindemann et al. · 2025 · Frontiers in Immunology
  77. Pulmonary Involvement in Systemic Lupus Erythematosus: A Potentially Overlooked Condition
    Ilaria Mormile, Gerardo Nazzaro, Marco Filippelli, Francesca Della Casa, Mauro Mormile, Amato de Paulis, Francesca Wanda Rossi · 2025 · Biomedicines
  78. Neutrophil extracellular traps and neuropsychiatric lupus: Signaling pathways involved in NET formation and mechanisms affecting the central nervous system
    Xin Guan, Xiaojie He, Lingjuan Liu · 2025 · Autoimmunity Reviews
  79. The Autoantigen Repertoire and the Microbial RNP World
    Sandra G. Williams, Sandra L. Wolin · 2021 · Trends in Molecular Medicine
  80. Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study
    Rebecca Heijke, Awais Ahmad, Martina Frodlund, Lina Wirestam, Örjan Dahlström, Charlotte Dahle, Stergios Kechagias, Christopher Sjöwall · 2021 · Journal of Clinical Medicine
  81. From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia
    Mishal F Kareemah, Rola Hassan, Ammar Z Faloudah, Lujain K Alharbi, Albraa F. Shodari, Ahmad A Rahbeeni, Nouf K Alharazi, Ahmed Z Binjabi, Mohamed Cheikh, Hanady Mansafi et al. · 2022 · Open Access Rheumatology Research and Reviews
  82. The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study
    Liliana Saraiva, Rachel Santana Cunha, Diogo Jesús, Mariele Gatto, Margherita Zen, Luca Iaccarino, José António Pereira da Silva, Andrea Doria, Luís Inês · 2023 · Rheumatology
  83. Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia
    Kelly Corbitt, Philip M. Carlucci, Brooke Cohen, Mala Masson, Amit Saxena, Michael H Belmont, Chung‐E Tseng, Kamil E. Barbour, Heather Taffet Gold, Jill P. Buyon et al. · 2024 · ACR Open Rheumatology
  84. The greatest contribution to medical science is the transformation from studying symptoms to studying their causes—the unrelenting legacy of Robert Koch and Louis Pasteur—and a causality perspective to approach a definition of SLE
    Ole Petter Rekvig · 2024 · Frontiers in Immunology
  85. Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus
    Wenqi Geng, Shangzhu Zhang, Jinya Cao, Xia Hong, Yanping Duan, Yinan Jiang, Jing Wei · 2024 · Frontiers in Immunology
  86. Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus
    Ruth D. Rodríguez, Marta Eugenia Alarcón-Riquelme · 2024 · Best Practice & Research Clinical Rheumatology
  87. The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment
    Huifang Xing, Hongping Liang · 2024 · PeerJ
  88. Infection versus disease activity in systemic lupus erythematosus patients with fever
    Rasha A. Abdel-Magied, Nehal W. Mokhtar, Noha M. Abdullah, Al-Shaimaa M. Abdel-Naiem · 2024 · BMC Rheumatology
  89. Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome criteria
    Benjamin D. Solomon, Purvesh Khatri · 2024 · Journal of Allergy and Clinical Immunology
  90. Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis
    Dalia Saad ElFeky, Noha Mohamed Omar, Olfat Gamil Shaker, Walaa Mahmoud Abdelrahman, Tamer Atef Gheita, Mona Gamal Nada · 2024 · Frontiers in Immunology
  91. Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation
    Patricia Richter, Minerva Codruța Bădescu, Ciprian Rezuș, Anca Ouatu, Nicoleta Dima, Diana Popescu, Alexandra Burlui, Ioana Bratoiu, Ioana Ruxandra Mihai, Elena Rezuş · 2024 · International Journal of Molecular Sciences
  92. Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort
    Murray B. Urowitz, Mary Elizabeth Jones, Zahi Touma, Jiandong Su, Juan Pablo Díaz-Martínez, Qinggong Fu, Roger A. Levy, Kerry Gairy, Anne Mackinnon, Nicole M. Anderson et al. · 2024 · Lupus Science & Medicine
  93. Impact of Systemic Lupus Erythematosus on Conception: Insights into Infertility, Fertility Preservation, Assisted Reproductive Technology, and Pregnancy Outcomes
    Amanda Moyer, Cuoghi Edens · 2024 · Seminars in Reproductive Medicine
  94. Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN
    Hiroyuki Teruya, Hirofumi Shoda, Takahiro Itamiya, Yumi Tsuchida, Tomohisa Okamura, Keishi Fujio · 2025 · Frontiers in Immunology
  95. EULAR /American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis
    Yongdong Zhao, Melissa S. Oliver, Anja Schnabel, Eveline Y. Wu, Zhaoyi Wang, Achille Marino, Cassyanne L. Aguiar, Jonathan Akikusa, Ümmüşen Kaya Akça, Beverley Almeida et al. · 2025 · Arthritis & Rheumatology
  96. Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases
    Hongmei Song · 2020 · World Journal of Pediatrics
  97. Proportions of B-cell subsets are altered in incomplete systemic lupus erythematosus and correlate with interferon score and IgG levels
    Svenja Henning, Wietske M. Lambers, Berber Doornbos‐van der Meer, Wayel Habib Abdulahad, Frans G. M. Kroese, Hendrika Bootsma, Johanna Westra, Karina de Leeuw · 2020 · Lara D. Veeken
  98. Chronic Oral Lesions
    Alaa F. Bukhari, Arwa Mohammad Farag, Nathaniel Simon Treister · 2020 · Dermatologic Clinics
  99. A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
    Roberta Vezza Alexander, Daniel Scott Rey, John Conklin, Vinicius Domingues, Mansoor Ahmed, Jazibeh Qureshi, Arthur Weinstein · 2021 · Lupus Science & Medicine
  100. Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes
    Yogita Ghodke‐Puranik, Zhongbo Jin, Kip D. Zimmerman, Hannah C. Ainsworth, Wei Fan, Mark A. Jensen, Jessica M. Dorschner, Danielle M. Vsetecka, Shreyasee Amin, Ashima Makol et al. · 2021 · Arthritis Research & Therapy